* price as on 19 Nov 2024
Financial
Mar-24A Mar-25F Mar-26F Mar-27F
Revenue (Rsm) 28,121 31,629 35,699 40,442
Operating EBITDA (Rsm) 1,443 2,158 2,966 3,455
Net Profit (Rsm) 753 947 1,432 1,753
Core EPS (Rs) 2.9 3.8 6.7 8.2
Core EPS Growth (20.2%) 31.6% 78.9% 22.4%
FD Core P/E (x) 64.13 51.09 33.79 27.60
DPS (Rs) 1.5 1.8 2.5 3.0
Dividend Yield 0.66% 0.77% 1.10% 1.32%
EV/EBITDA (x) 33.13 22.02 15.77 13.27
P/FCFE (x) (77.39) 94.20 46.28 35.89
Net Gearing (7.1%) (12.6%) (20.5%) (28.4%)
P/BV (x) 7.55 6.95 6.16 5.39
ROE 9.9% 12.0% 19.3% 20.8%
% Change In Core EPS Estimates
InCred Research/Consensus EPS (x)
(Rs mn) Mar-24A Mar-25F Mar-26F Mar-27F
Total Net Revenues 28,121 31,629 35,699 40,442
Gross Profit 8,551 10,223 11,424 12,892
Operating EBITDA 1,443 2,158 2,966 3,455
Depreciation And Amortisation (590) (958) (898) (981)
Operating EBIT 853 1,200 2,068 2,474
Financial Income/(Expense) (160) (195) (175) (156)
Pretax Income/(Loss) from Assoc.
Non-Operating Income/(Expense) 82 14 17 20
Profit Before Tax (pre-EI) 776 1,018 1,909 2,338
Exceptional Items 187 187
Pre-tax Profit 963 1,205 1,909 2,338
Taxation (210) (258) (477) (584)
Exceptional Income - post-tax
Profit After Tax 753 947 1,432 1,753
Minority Interests
Preferred Dividends
FX Gain/(Loss) - post tax
Other Adjustments - post-tax
Net Profit 753 947 1,432 1,753
Recurring Net Profit 607 800 1,432 1,753
Fully Diluted Recurring Net Profit 607 800 1,432 1,753
(Rs mn) Mar-24A Mar-25F Mar-26F Mar-27F
EBITDA 1,443 2,158 2,966 3,455
Cash Flow from Invt. & Assoc.
Change In Working Capital (443) (227) (264) (307)
(Incr)/Decr in Total Provisions
Other Non-Cash (Income)/Expense
Other Operating Cashflow 206 (263) (462) (480)
Net Interest (Paid)/Received 33 195 175 156
Tax Paid (57) (258) (477) (584)
Cashflow From Operations 1,183 1,604 1,938 2,239
Capex (1,400) (675) (493) (512)
Disposals Of FAs/subsidiaries
Acq. Of Subsidiaries/investments (376) (500) (500) (500)
Other Investing Cashflow 70 84 101 121
Cash Flow From Investing (1,705) (1,091) (892) (891)
Debt Raised/(repaid) (100)
Proceeds From Issue Of Shares 1
Shares Repurchased
Dividends Paid (320) (373) (534) (640)
Preferred Dividends
Other Financing Cashflow (37) (279) (276) (277)
Cash Flow From Financing (457) (653) (809) (917)
Total Cash Generated (980) (140) 236 431
Free Cashflow To Equity (623) 513 1,046 1,348
Free Cashflow To Firm (629) 234 770 1,071
(Rs mn) Mar-24A Mar-25F Mar-26F Mar-27F
Total Cash And Equivalents 663 1,087 1,823 2,754
Total Debtors 4,620 5,196 5,865 6,644
Inventories 3,151 3,544 4,000 4,531
Total Other Current Assets 761 856 966 1,094
Total Current Assets 9,194 10,682 12,653 15,023
Fixed Assets 1,537 3,652 3,550 3,425
Total Investments
Intangible Assets
Total Other Non-Current Assets 3,778 1,585 1,585 1,585
Total Non-current Assets 5,316 5,237 5,135 5,010
Short-term Debt 209 209 209 209
Current Portion of Long-Term Debt
Total Creditors 5,439 6,118 6,905 7,822
Other Current Liabilities 1,269 1,427 1,611 1,825
Total Current Liabilities 6,917 7,754 8,725 9,856
Total Long-term Debt
Hybrid Debt - Debt Component
Total Other Non-Current Liabilities 1,202 1,202 1,202 1,202
Total Non-current Liabilities 1,202 1,202 1,202 1,202
Total Provisions
Total Liabilities 8,119 8,956 9,927 11,058
Shareholders Equity 6,389 6,963 7,862 8,975
Minority Interests
Total Equity 6,389 6,963 7,862 8,975
Mar-24A Mar-25F Mar-26F Mar-27F
Revenue Growth 11.2% 12.5% 12.9% 13.3%
Operating EBITDA Growth (4.4%) 49.5% 37.5% 16.5%
Operating EBITDA Margin 5.1% 6.8% 8.3% 8.5%
Net Cash Per Share (Rs) 2.14 4.11 7.57 11.93
BVPS (Rs) 30.03 32.63 36.85 42.06
Gross Interest Cover 3.67 4.30 7.49 8.93
Effective Tax Rate 21.8% 21.4% 25.0% 25.0%
Net Dividend Payout Ratio 41.3% 36.7% 27.9% 27.4%
Accounts Receivables Days 53.08 56.64 56.54 56.44
Inventory Days 55.93 57.07 56.71 56.51
Accounts Payables Days 92.96 98.53 97.90 97.55
ROIC (%) 15.6% 16.8% 28.4% 33.2%
ROCE (%) 14.8% 18.6% 28.5% 30.1%
Return On Average Assets 6.9% 8.0% 12.4% 13.2%

Analyst(s)

Arafat SAIYED

(91) 22 4161 1542 arafat.saiyed@incredresearch.com

Anirvan DIVAKERA

(91) 02241611548 anirvan.divakera@incredresearch.com